No. 4 Medical Innovation for 2020: Therapy for Peanut Allergies

Oral immunotherapy drug is first of its kind

About 8% of U.S. children have a food allergy, and that number is on the rise. Avoiding the allergic trigger is recommended, but it’s not always possible.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Desensitization therapy, while not a cure, may alleviate some fear of accidental exposure by training the immune system to adapt.

In September 2019, an FDA expert panel recommended approval of a first-of-its-kind treatment — an oral immunotherapy medication to gradually build tolerance to peanut exposure.

In this video, learn more about why this therapy for peanut allergies is one of Cleveland Clinic’s Top 10 Medical Innovations for 2020.

Related Articles

Photo of Tom Mihaljevic, MD, and Gary Cohn
A Fireside Chat about Digital Technology in Healthcare

Cleveland Clinic and IBM leaders share insights, concerns, optimism about impacts

23-CCC-4375920 Zipline drone delivery 650×450
Delivering Drugs via Drone

Cleveland Clinic will offer rapid, pinpoint airborne transport of medications and other medical items

SEM_Knipfer_3797162_Mentor Hospital Community Grand Opening_06-2
How Cleveland Clinic Is Greening Its Operating Rooms

Dedicated committee and surgical fellowship strive for sustainability, energy efficiency, waste reduction

Top 10 Medical Innovations for 2022 Unveiled

Next-generation mRNA vaccines are among the advancements likely to change healthcare this year

Why Lead Safety Has Become Cleveland Clinic’s Top Priority for Community Health

$50 million pledge will help remove sources of lead exposure from Cleveland homes

Nurse conducts safety check on medications in hospital hallway
10 Leadership Mindsets for High Reliability Organizations

How to empower caregivers and engage patients in patient safety

10 Things Not To Miss at MIS2020

Summit to cap off with Annual Top 10 Medical Innovations

Thomas Mroz, MD, Named Chair of the Orthopaedic & Rheumatologic Institute

The spine surgeon will oversee more than 125 staff physicians in his new role